BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 23262097)

  • 1. [The cooperation between p53 and Ras in tumorigenesis].
    Wei YY; Hou J; Tang WR; Luo Y
    Yi Chuan; 2012 Dec; 34(12):1513-21. PubMed ID: 23262097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of the p53 tumor suppressor gene and activation of the Ras oncogene: cooperative events in tumorigenesis.
    Solomon H; Brosh R; Buganim Y; Rotter V
    Discov Med; 2010 May; 9(48):448-54. PubMed ID: 20515613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide SNP analysis of Tg.AC transgenic mice reveals an oncogenic collaboration between v-Ha-ras and Ink4a, which is absent in p53 deficiency.
    Leder A; McMenamin J; Zhou F; Moran JL; Beier DR; Leder P
    Oncogene; 2008 Apr; 27(17):2456-65. PubMed ID: 17952114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the NORE1A tumor suppressor in Oncogene-Induced Senescence.
    Barnoud T; Schmidt ML; Donninger H; Clark GJ
    Cancer Lett; 2017 Aug; 400():30-36. PubMed ID: 28455242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs: small but potent oncogenes or tumor suppressors.
    Lee YS; Dutta A
    Curr Opin Investig Drugs; 2006 Jun; 7(6):560-4. PubMed ID: 16784027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis.
    Sarkisian CJ; Keister BA; Stairs DB; Boxer RB; Moody SE; Chodosh LA
    Nat Cell Biol; 2007 May; 9(5):493-505. PubMed ID: 17450133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-cadherin and keratinocyte growth factor receptor mediate the functional interplay between Ki-RASG12V and p53V143A in promoting pancreatic cell migration, invasion, and tissue architecture disruption.
    Deramaudt TB; Takaoka M; Upadhyay R; Bowser MJ; Porter J; Lee A; Rhoades B; Johnstone CN; Weissleder R; Hingorani SR; Mahmood U; Rustgi AK
    Mol Cell Biol; 2006 Jun; 26(11):4185-200. PubMed ID: 16705170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunophenotype, ras oncogenes and p53 onco-suppressor gene in benzo(a)pyrene induced malignant soft tissue tumours in Wistar rats.
    Stefanou DG; Nonni AV; Kalpouzos G; Evangelou A; Agnantis NJ
    In Vivo; 1998; 12(5):511-21. PubMed ID: 9827359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-137 Modulates a Tumor Suppressor Network-Inducing Senescence in Pancreatic Cancer Cells.
    Neault M; Mallette FA; Richard S
    Cell Rep; 2016 Mar; 14(8):1966-78. PubMed ID: 26904954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of p21 and p53 expression in gastric cancer.
    Seo YH; Joo YE; Choi SK; Rew JS; Park CS; Kim SJ
    Korean J Intern Med; 2003 Jun; 18(2):98-103. PubMed ID: 12872447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of proto-oncogene activation in carcinogenesis.
    Anderson MW; Reynolds SH; You M; Maronpot RM
    Environ Health Perspect; 1992 Nov; 98():13-24. PubMed ID: 1486840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular senescence induced by p53-ras cooperation is independent of p21waf1 in murine embryo fibroblasts.
    Castro ME; del Valle Guijarro M; Moneo V; Carnero A
    J Cell Biochem; 2004 Jun; 92(3):514-24. PubMed ID: 15156563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogenic ras activates the ARF-p53 pathway to suppress epithelial cell transformation.
    Lin AW; Lowe SW
    Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5025-30. PubMed ID: 11309506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. K-ras mutations and p53 alterations in neoplastic and nonneoplastic lesions associated with longstanding ulcerative colitis.
    Chaubert P; Benhattar J; Saraga E; Costa J
    Am J Pathol; 1994 Apr; 144(4):767-75. PubMed ID: 8160776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. REDD1, a new Ras oncogenic effector.
    Smith ER; Xu XX
    Cell Cycle; 2009 Mar; 8(5):675-6. PubMed ID: 19242117
    [No Abstract]   [Full Text] [Related]  

  • 16. Regulation of p53 by ING family members in suppression of tumor initiation and progression.
    Jafarnejad SM; Li G
    Cancer Metastasis Rev; 2012 Jun; 31(1-2):55-73. PubMed ID: 22095030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and significance of p53, rb, p21/waf-1, p16/ink-4a, and PTEN tumor suppressors in canine melanoma.
    Koenig A; Bianco SR; Fosmire S; Wojcieszyn J; Modiano JF
    Vet Pathol; 2002 Jul; 39(4):458-72. PubMed ID: 12126149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of cellular senescence by oncogenic RAS.
    Gupta R; Wajapeyee N
    Methods Mol Biol; 2013; 1048():127-33. PubMed ID: 23929102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity within and between primary colorectal carcinomas and matched metastases as revealed by analysis of Ki-ras and p53 mutations.
    Albanese I; Scibetta AG; Migliavacca M; Russo A; Bazan V; Tomasino RM; Colomba P; Tagliavia M; La Farina M
    Biochem Biophys Res Commun; 2004 Dec; 325(3):784-91. PubMed ID: 15541358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual inactivation of RB and p53 pathways in RAS-induced melanomas.
    Bardeesy N; Bastian BC; Hezel A; Pinkel D; DePinho RA; Chin L
    Mol Cell Biol; 2001 Mar; 21(6):2144-53. PubMed ID: 11238948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.